Ms. Roberta Duncan

Roberta Duncan is currently the Chief Strategy Officer, Arcturus Therapeutics and Vice Chair on the Board of Alliance for mRNA Medicines (AMM). Roberta has been in the biopharma industry for more than 26 years with experience from start-up and small biotech to pharma and CROs. Most recently, Roberta was Vice President leading CSL’s mRNA Program. Roberta has a proven track record, across industry-leading organizations, of leading innovative, complex programs across multiple therapeutic areas and business functions. She earned her BA in Biochemistry from New York University, as well as two MBAs in International Management and Strategy from Krannert School of Management and TiasNimbas Business School.